Mutual of Omaha Life Insurance Fit Review for Type 1 Diabetes

Research Snapshot

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

• Is Mutual of Omaha a good choice for life insurance for Type 1 diabetes?
• Why did AI platforms include Mutual of Omaha in a Type 1 diabetes life insurance ranking?

Mutual of Omaha qualified because it was named by six of the seven platforms during ranking discovery, the second-widest mention footprint in this study, and because it is one of the few carriers in the set that publishes a distinct simplified-issue and guaranteed-issue path alongside fully underwritten term ^[7]. That combination matters for a condition where underwriting outcomes range from standard to decline.

Platforms did not agree on how good the fit is. Two platforms rated it "good" (anthropic, kimi) and five rated it "mixed" (deepseek, google, grok, openai, perplexity). The disagreement tracks a real split in the evidence: company-owned documents show a restrictive Express underwriting rule, while independent broker reviews describe the same carrier as comparatively forgiving for controlled diabetes ^[10].

Financial strength was not a point of dispute. Mutual of Omaha holds an A+ rating from AM Best and an A+ from S&P Global, and ranked first among 23 insurers in J.D. Power's 2025 U.S. life insurance Study with a score of 707 out of 1,000 ^[13]. The company reported paying over $8.1 billion in benefits in 2024 with more than 6.7 million active policies ^[15].

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Type 1 Diabetes

Questions This Section Answers

• Which Mutual of Omaha plan should a buyer with Type 1 diabetes apply for first?
• Does Mutual of Omaha Term Life Express accept Type 1 diabetes diagnosed before age 45?

Four products matter for this use case, and they behave very differently.

Term Life Answers is the fully underwritten term product. It is identified in Mutual of Omaha's fluidless underwriting materials as a fully underwritten product, and a fluidless pathway is limited to specified ages, face amounts, products, and underwriting parameters ^[16]. Independent reviews describe it as available from ages 18 to 80 with a $100,000 coverage minimum and 10-, 15-, 20-, or 30-year terms ^[17]. Full underwriting is the route that allows A1C, glucose control, insulin regimen, and complication history to be reviewed rather than screened out by a single question.

Term Life Express is the simplified-issue, no-exam term product. It is marketed with face amounts of $25,000 to $550,000 and 10-, 15-, 20-, and 30-year terms ^[21], with issue ages of 18 to 75 ^[23]. This is the product most affected by the diabetes rule described below.

Living Promise is a whole life product with simplified underwriting. Published materials list issue ages of 45 to 85 for the level-benefit plan and 45 to 80 for the graded-benefit plan, with face amounts of $2,000 to $50,000 for level benefit and $2,000 to $20,000 for graded benefit, plus a $36 annual policy fee on the level plan and $12 on the graded plan ^[24]. Independent reviews describe it as covering ages 45 to 85 with $2,000 to $25,000 in benefit and no medical exam ^[25].

Guaranteed-issue whole life is the no-health-question path. Mutual of Omaha's own materials state that its whole-life guaranteed issue product is not subject to medical underwriting ^[26], and independent sources describe guaranteed-issue coverage as available to ages 45 to 85 with no health questions and up to $25,000 in coverage ^[27]. Company consumer material describes guaranteed-issue life insurance generally as requiring no medical exam or health questions, but does not establish that the reviewed Living Promise product is itself guaranteed issue ^[28].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Mutual of Omaha and Type 1 diabetes underwriting?
• Is Mutual of Omaha's simplified-issue underwriting restrictive for Type 1 diabetes?

Agreement was strongest on the restrictive simplified-issue rule. Five platforms cited the same company document showing that diabetes diagnosed before age 45 is an automatic decline on the Express products, and that diabetes with complications is also a decline ^[29]. One source dates the change to April 22, 2023, when the company lowered the diabetes automatic-decline age to 45 ^[35].

Platforms also agreed that the guaranteed-issue and simplified-issue paths are the most accessible routes for this buyer, and that guaranteed-issue coverage is small. Independent sources describe guaranteed-issue policy amounts as modest, usually up to $25,000 ^[36], and one review notes that guaranteed-issue coverage is aimed at older adults and small final-expense needs ^[37].

A third area of agreement: pricing for a Type 1 diabetes applicant is not publicly verifiable. No platform found published Type 1-specific rate classes, A1C thresholds, or insulin-use rules from Mutual of Omaha (openai, deepseek, kimi, perplexity all flagged this). Independent guidance indicates Type 1 diabetes applicants often face higher premiums or modified offers, with outcomes depending on control and complications ^[38].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Do independent reviews say Mutual of Omaha is lenient or strict for Type 1 diabetes?
• Is Mutual of Omaha Living Promise guaranteed issue or simplified issue?

The sharpest disagreement is whether Mutual of Omaha is lenient or strict for diabetes. Independent broker reviews describe its underwriting as more forgiving than competitors for conditions like controlled diabetes ^[39], and one review states that Express and Living Promise products accept controlled diabetes and past heart events outside the lookback window ^[41]. Company-owned documents show the opposite for early-diagnosis diabetes. Both can be true if "controlled diabetes" in those reviews refers mainly to Type 2, which the Express guide does not distinguish from Type 1 (openai).

The second disagreement concerns Living Promise. One platform's sources describe it as guaranteed issue with no health questions ^[42], while independent reviews state it is no-exam but not guaranteed acceptance and still uses health questions ^[43]. Mutual of Omaha's own Living Promise materials describe simplified underwriting and level or graded benefit plans, not universal guaranteed acceptance ^[45]. Buyers should treat the guaranteed-issue label as product-specific and confirm which contract is being quoted.

A third uncertainty: the exact decline age. Most sources cite 45, but one notes the cutoff varies slightly by source and state, citing 45 versus 50 (grok). One independent source states that Living Promise forces applicants diagnosed with diabetes before age 49 into the graded benefit plan ^[46].

A fourth: whether the Fit underwriting credit program helps this buyer. One platform reports that Type 1 diabetes is excluded from the Fit program credit ^[47], while another describes a Fit credit program that lowers rates for good health markers without confirming diabetes eligibility ^[49]. This is unresolved.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What coverage amounts can a Type 1 diabetes applicant get from Mutual of Omaha Term Life Express?
• How does Mutual of Omaha handle A1C, insulin use, and kidney health in underwriting?

Coverage capacity splits sharply by product. Term Life Express reaches $25,000 to $550,000 ^[50]. Term Life Answers starts at $100,000 with no stated upper limit in the reviewed sources ^[52]. Living Promise and guaranteed-issue whole life are capped in the $2,000 to $50,000 range depending on plan and state ^[54]. For income replacement, only the term products are relevant.

On the medical factors this buyer cares about, the public record is thin. Mutual of Omaha's no-exam information states that a life insurance medical exam can identify conditions such as diabetes and kidney problems ^[57], which signals that diabetes history and related health information will be addressed in the application. But no reviewed source discloses the company's complete Type 1 diabetes rating table, A1C thresholds, insulin-use rules, or complication lookback windows. One independent underwriting guide cited by a platform indicates Type I diabetes over age 20 typically lands at Table 2-8 on fully underwritten coverage ^[58], and another independent source describes fully underwritten diabetes candidates as reviewed case by case with outcomes from Standard to Table 8 ^[59].

Underwriting discretion is explicit in company materials: Mutual of Omaha application materials state that medical exams, physician statements, records, and other underwriting information may be required, and that issuance depends on eligibility under current underwriting standards ^[61]. An independent review notes the underwriter may order an attending physician statement to clarify application information ^[62]. The NAIC notes that accelerated underwriting does not always result in issuance and that some applicants are moved to traditional underwriting ^[63].

Conversion is a genuine feature. Independent reviews state that Term Life Express and Term Life Answers can convert to permanent coverage without additional underwriting after two or more years of coverage, with rates locked to the original approval class (anthropic). This is platform-reported and should be confirmed in the contract.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Mutual of Omaha cost per month for a Type 1 diabetes applicant?
• What policy fees and waiting periods apply to Mutual of Omaha Living Promise and guaranteed-issue whole life?

No platform verified an actual premium for a Type 1 diabetes applicant. Pricing depends on age, sex, tobacco status, coverage amount, term length, state, diabetes history, laboratory results, complications, and underwriting class (openai). Treat any figure below as a general reference point, not a quote.

Two structural cost facts matter more than any single number. First, simplified and accelerated underwriting can involve higher premiums than fully underwritten coverage, according to the NAIC ^[64]. Second, guaranteed-issue coverage carries a higher cost per $1,000 of coverage because there is no health underwriting (anthropic, deepseek).

Contract terms reported by platforms include a 30-day free look period, a two-year contestability period, and a graded benefit structure that refunds only paid premiums plus 10% if death occurs from natural causes in the first two years (google). Living Promise is stated to be guaranteed to age 100 as long as premiums are paid ^[65]. One platform notes a two-year graded benefit period on guaranteed-issue whole life (anthropic). These terms are platform-reported and vary by state and product.

Best Suited For

Questions This Section Answers

• Who is Mutual of Omaha actually a good fit for with Type 1 diabetes?
• Is Mutual of Omaha worth it for a Type 1 diabetes applicant who wants a no-exam policy?

Mutual of Omaha is best suited for three buyer profiles, based on the balance of platform findings.

First, an adult with Type 1 diabetes who is willing to complete full underwriting and can supply strong, recent medical documentation. Term Life Answers is the product that allows A1C, glucose control, insulin regimen, and complication history to be evaluated rather than screened by a single question ^[66].

Second, an applicant age 45 or older who needs limited final-expense coverage and meets Living Promise issue-age and face-amount limits ^[68].

Third, an applicant who cannot pass health questions at all and needs a small guaranteed-issue policy as a baseline ^[70]. Two platforms rated the overall fit "good" (anthropic, kimi), largely on the strength of these fallback paths.

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Mutual of Omaha for life insurance with Type 1 diabetes?
• Is Mutual of Omaha a bad choice for a Type 1 diabetes applicant diagnosed in childhood?

An adult diagnosed with Type 1 diabetes before age 45 who wants a no-exam Term Life Express policy is the clearest poor fit. The published Express guide lists diabetes diagnosed before age 45 as an automatic decline ^[72]. Because Type 1 diabetes is commonly diagnosed before age 45, this rule excludes a large share of this buyer group from the simplified-issue path.

Buyers needing large death benefits through simplified or guaranteed issue are also poorly served. Guaranteed-issue coverage is capped around $25,000 ^[75], and Living Promise face amounts top out at $50,000 on the level plan ^[77]. Neither substitutes for income replacement.

Applicants with diabetic complications face a second published decline trigger: diabetes with complications is listed as a decline on the Express products ^[72]. One platform also reports that Type 1 diabetes is excluded from the Fit underwriting credit program, meaning this buyer may not be able to offset a substandard rating through healthy-habit credits ^[79].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Mutual of Omaha for a Type 1 diabetes applicant who wants the lowest premium?
• When should a Type 1 diabetes buyer use a specialized broker instead of applying directly to Mutual of Omaha?

Another carrier may be better in four situations identified across platforms.

When the buyer is under 45 with Type 1 diabetes and wants fully underwritten term, platforms point to AIG, Transamerica, Assurity, or MassMutual as having broader age acceptance (anthropic). When the buyer is young and healthy and wants the lowest rate, Banner Life, Protective Life, or Lincoln Financial are cited as offering lower fully underwritten term rates (anthropic, kimi). When the buyer wants a diabetes-specific program with rewards or premium discounts, John Hancock Aspire is the only provider in the reviewed set with a program designed specifically for people with diabetes ^[81]. When the buyer needs large permanent coverage with cash value, Mutual of Omaha's whole life is final-expense focused, and traditional mutual companies offer larger cash-value whole life policies (anthropic).

A specialized independent broker may be better when the buyer wants a carrier-by-carrier pre-underwriting comparison focused on Type 1 diabetes, or when the buyer needs an informal underwriting opinion before submitting a formal application (openai). One independent source notes that Mutual of Omaha is not a "bad" provider but is simply more expensive than other companies for this profile ^[82].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Mutual of Omaha before signing a Type 1 diabetes life insurance contract?
• Will Mutual of Omaha consider a Type 1 diabetes applicant diagnosed before age 45 for Term Life Answers?

These questions come directly from the platform research and target the gaps in the public record.

• Will Mutual of Omaha or United of Omaha consider an adult diagnosed with Type 1 diabetes before age 45 for Term Life Answers or another fully underwritten product (openai)?
• Does the published pre-age-45 diabetes decline apply to Type 1 diabetes under the exact product and state being applied for (openai, anthropic)?
• What A1C range, duration of control, glucose-monitoring records, insulin regimen, and hypoglycemia history will underwriting review (openai, anthropic)?
• How will kidney function, albuminuria, retinopathy, neuropathy, cardiovascular disease, blood pressure, and diabetes-related hospitalizations affect eligibility and rate class (openai, perplexity)?
• Can the agent obtain an anonymous or informal underwriting opinion before a formal application and medical exam (openai)?
• Is Living Promise available at the buyer's age, what is the exact level-versus-graded benefit schedule, and is acceptance guaranteed or subject to health questions (openai, perplexity)?
• Is the proposed policy issued by Mutual of Omaha Insurance Company, United of Omaha Life Insurance Company, or another affiliate (openai, deepseek)?
• What are the policy fee, modal premium factors, rider charges, renewal terms, conversion terms, contestability provisions, and lapse consequences (openai, anthropic)?

Final AI Consensus Verdict

Mutual of Omaha is a mixed fit for life insurance with Type 1 diabetes, and the split is structural rather than marginal. Six of seven platforms named it, and it ranked fourth on average, but only two platforms rated the fit "good" while five rated it "mixed."

The case for it rests on product breadth: a fully underwritten term path for buyers who can document stable control, a simplified-issue term path for those who clear the health questions, and a guaranteed-issue whole life path for those who cannot. The case against it rests on a published rule that closes the simplified-issue door to anyone diagnosed with diabetes before age 45, plus a complications decline and a small guaranteed-issue ceiling.

The practical verdict: Mutual of Omaha is worth an individual underwriting inquiry, ideally informal, for a medically stable adult with Type 1 diabetes, especially through fully underwritten Term Life Answers. It is not a general solution for substantial coverage, and it should not be the only carrier quoted. Buyers who want the full picture of how this carrier compares with the rest of the field can review the Life Insurance for Type 1 Diabetes consensus index, and those starting from the broader category can browse life insurance options for high-risk health conditions.

How This Review Was Produced

This review synthesizes seven platform responses collected for the query: which life insurance carriers are generally worth considering for applicants with Type 1 diabetes. Each platform evaluated Mutual of Omaha's fit for that specific use case, supplied supporting citations, and rated the fit. Six of the seven platforms named Mutual of Omaha during ranking discovery; the seventh did not, and its response is excluded from mention counts but retained in the evidence set where it contributed context.

Ranking statistics reflect the discovery stage only. Fit ratings, product findings, and limitations reflect each platform's own analysis and are reported as platform-reported evidence, not independently verified facts. Company-owned documents are identified as owned sources; broker reviews, journalism, and directories are identified as independent. No platform conducted personal testing, and no platform verified a live premium for a Type 1 diabetes applicant.

Methodology Limitations

Several limitations apply to every finding above.

Platform-reported research dates differ from the authoritative run date of 2026-09-22. Six platforms reported 2026-09-23; one reported 2026-01-15 (deepseek). Platform dates are provenance metadata and do not independently prove freshness.

One platform ran without search enabled (deepseek), so its claims rest on model knowledge rather than retrieved documents and require explicit verification before being treated as current.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts.

Material conflicts remain unresolved. Sources disagree on whether Living Promise is guaranteed issue or simplified issue, on whether the diabetes decline age is 45 or 50, and on whether Mutual of Omaha's underwriting is lenient or strict for diabetes. The Express guide uses a diagnosis-age cutoff but does not expressly distinguish Type 1 from Type 2 diabetes, which limits how precisely any finding applies to this buyer.

Current premiums and Type 1 diabetes rating classes were not publicly verified by any platform. The reviewed official materials do not establish that Living Promise is guaranteed issue. Guaranteed acceptance for an adult with Type 1 diabetes was not verified. The requested product list combines Mutual of Omaha and United of Omaha product names, and the reviewed materials identify United of Omaha as the underwriter for certain life products, so the issuing company and state availability must be confirmed.